Skip to main content
Search
Newsletters
Watchlist
Home
Watchlist
For You
Canada
World
Business
Investing
Personal Finance
Opinion
Politics
Sports
Life
Arts
Drive
Real Estate
Latest in
TSX Today:
MFC-T
+1.15%
WEED-T
+11.22%
ENB-T
-0.54%
TLRY-T
+3.2%
SU-T
+1.06%
HNU-T
+4.63%
CVE-T
-0.87%
Search stocks, ETFs and Commodities
Instrument Name
Fireman B.V.
Instrument Symbol
(IFRX-Q)
Instrument Exchange
NASDAQ
Add to Watchlist
Create Alerts
USD
Today's Change
Real-Time
Last Update
Last Sale
Cboe BZX Real-Time
USD
Pre Market
Change
Pre Market
Last Update
Pre Market
Price
Volume
Summary
Charts
Profile
Financials
Statistics
Dividends
Price History
Analyst Estimates
Insiders
Fireman B.V.
WINZERLAER STR. 2
JENA 2M 07745 DEU
P:
49-36-4150-8180
http://www.inflarx.de
Sectors & Indices
Sector
Industry
Employees
SIC-2834 Pharmaceutical Preparations
Medical - Biomedical
Profile
InflaRx N.V. is a clinical-stage biopharmaceutical company. It focused on applying its proprietary anti-C5a technology to discover and develop first-in-class, potent and specific inhibitors of C5a. InflaRx N.V. is based in Germany.
Key Executives
Name
Title
Niels Riedemann
CEO/Co-Founder/Director
Renfeng Guo
Chief Scientific Officer/Co-Founder/Director
Thomas Taapken
CFO
Camilla Chong
Chief Medical Officer
Derval O’Carroll
Other Corporate Officer/Senior VP
More from The Globe
opinion
Here’s the real reason your Canadian stocks can’t keep up
Tim Shufelt
1 hour ago
Premarket: Global stocks drift after Fed officials hint interest rates may not fall soon
2 hours ago
number cruncher
U.S technology stocks with earnings and price momentum
Yesterday
Lightspeed Commerce stock soars on better-than-expected profit forecast
Yesterday
GameStop, AMC dive further as meme stocks rally tapers off
Yesterday
The close: Dow briefly hits 40,000 milestone, TSX rises on upbeat earnings
Yesterday
Proxy advisers recommend investors vote ‘no’ on Shopify executive pay
May 15, 2024
The close: Wall Street boasts fresh records as inflation data fuels rate-cut bets
May 15, 2024